Nalaganje...
Identifying factors associated with clinical success in patients treated with NASHA(®)/Dx injection for fecal incontinence
PURPOSE: Injection with the bulking agent consisting of non-animal stabilized hyaluronic acid/dextranomer (NASHA(®)/Dx) is well tolerated and efficacious for the treatment of fecal incontinence (FI); however, the patient population that may derive maximum benefit has not been established. This post...
Shranjeno v:
| izdano v: | Clin Exp Gastroenterol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4780737/ https://ncbi.nlm.nih.gov/pubmed/27042136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S95238 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|